Literature DB >> 20199796

Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits.

Tomasz Fraczyk1, Konrad Kubiński, Maciej Masłyk, Joanna Cieśla, Ulf Hellman, David Shugar, Wojciech Rode.   

Abstract

Thymidylate synthase (TS) was found to be a substrate for both catalytic subunits of human CK2, with phosphorylation by CK2alpha and CK2alpha' characterized by similar K(m) values, 4.6microM and 4.2microM, respectively, but different efficiencies, the apparent turnover number with CK2alpha being 10-fold higher. With both catalytic subunits, phosphorylation of human TS, like calmodulin and BID, was strongly inhibited in the presence of the regulatory subunit CK2beta, the holoenzyme being activated by polylysine. Phosphorylation of recombinant human, rat, mouse and Trichinella spiralis TSs proteins was compared, with the human enzyme being apparently a much better substrate than the others. Following hydrolysis and TLC, phosphoserine was detected in human and rat, and phosphotyrosine in T. spiralis, TS, used as substrates for CK2alpha. MALDI-TOF MS analysis led to identification of phosphorylated Ser(124) in human TS, within a sequence LGFS(124)TREEGD, atypical for a CK2 substrate recognition site. The phosphorylation site is located in a region considered important for the catalytic mechanism or regulation of human TS, corresponding to the loop 107-128. Following phosphorylation by CK2alpha, resulting in incorporation of 0.4mol of phosphate per mol of dimeric TS, human TS exhibits unaltered K(m) values for dUMP and N(5,10)-methylenetetrahydrofolate, but a 50% lower turnover number, pointing to a strong influence of Ser(124) phosphorylation on its catalytic efficiency. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199796     DOI: 10.1016/j.bioorg.2010.02.001

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  9 in total

1.  Mechanism of influence of phosphorylation on serine 124 on a decrease of catalytic activity of human thymidylate synthase.

Authors:  Adam Jarmuła; Tomasz Fraczyk; Piotr Cieplak; Wojciech Rode
Journal:  Bioorg Med Chem       Date:  2010-04-09       Impact factor: 3.641

2.  Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions, phosphorylation, and inhibition profiles.

Authors:  BeiBei Luo; Jayanthi Repalli; Al-Motassem Yousef; Saphronia R Johnson; Lukasz Lebioda; Sondra H Berger
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

3.  Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer.

Authors:  Ninon Very; Stéphan Hardivillé; Amélie Decourcelle; Julien Thévenet; Madjid Djouina; Adeline Page; Gérard Vergoten; Céline Schulz; Julie Kerr-Conte; Tony Lefebvre; Vanessa Dehennaut; Ikram El Yazidi-Belkoura
Journal:  Oncogene       Date:  2021-11-29       Impact factor: 9.867

4.  Molecular Mechanism of Thymidylate Synthase Inhibition by N4-Hydroxy-dCMP in View of Spectrophotometric and Crystallographic Studies.

Authors:  Piotr Maj; Adam Jarmuła; Piotr Wilk; Małgorzata Prokopowicz; Wojciech Rypniewski; Zbigniew Zieliński; Anna Dowierciał; Agnieszka Bzowska; Wojciech Rode
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

5.  Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1.

Authors:  Konrad Kubiński; Maciej Masłyk; Andrzej Orzeszko
Journal:  Mol Cell Biochem       Date:  2016-12-01       Impact factor: 3.396

6.  Inhibition of Protein Kinase CK2 Affects Thymidylate Synthesis Cycle Enzyme Level and Distribution in Human Cancer Cells.

Authors:  Patrycja Wińska; Łukasz Widło; Elżbieta Senkara; Mirosława Koronkiewicz; Jarosław M Cieśla; Alicja Krzyśko; Katarzyna Skierka; Joanna Cieśla
Journal:  Front Mol Biosci       Date:  2022-02-25

7.  Dynamic allostery in substrate binding by human thymidylate synthase.

Authors:  Jeffrey P Bonin; Paul J Sapienza; Andrew L Lee
Journal:  Elife       Date:  2022-10-06       Impact factor: 8.713

Review 8.  Drug resistance related to aberrant glycosylation in colorectal cancer.

Authors:  Ninon Very; Tony Lefebvre; Ikram El Yazidi-Belkoura
Journal:  Oncotarget       Date:  2017-11-03

9.  Synergistic Interactions of 5-Fluorouracil with Inhibitors of Protein Kinase CK2 Correlate with p38 MAPK Activation and FAK Inhibition in the Triple-Negative Breast Cancer Cell Line.

Authors:  Patrycja Wińska; Olena Karatsai; Monika Staniszewska; Mirosława Koronkiewicz; Konrad Chojnacki; Maria Jolanta Rędowicz
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.